Biophytis S.A.
PAR: ALBPS.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stanislas Veillet
- Employees
- 22
- Headquarters
- Paris, France
- IPO year
- 2015
- Market cap
- €487.8K
- Website
- https://www.biophytis.com
Loading ALBPS…
Loading profile data…Frequently asked questions about ALBPS
What does Biophytis S.A. (ALBPS.PA) do?
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract...
Where does ALBPS.PA trade?
Biophytis S.A. (ALBPS.PA) trades on the Euronext Paris.
What sector is ALBPS.PA in?
Biophytis S.A. (ALBPS.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biophytis S.A.?
Stanislas Veillet is the chief executive officer of Biophytis S.A. (ALBPS.PA).
Where is Biophytis S.A. headquartered?
Biophytis S.A. is headquartered in France.
Does ALBPS.PA pay a dividend?
Biophytis S.A. (ALBPS.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALBPS.PA go public?
Biophytis S.A. (ALBPS.PA) completed its initial public offering in 2015.